The Biotechnology Industry Organization announced that Washington State Gov. Jay Inslee will provide a keynote address at the 3rd annual BIO Convention in China to be held Nov. 11-13, in Beijing.
According to a release, Gov. Inslee's plenary keynote address will take place on Tuesday, Nov. 12.
The event will bring together biotechnology executives, pharmaceutical companies and investment firms to meet and explore business opportunities within China's biotech sector.
"We are thrilled that Governor Inslee will be joining us in China this year. The governor has been tireless in his efforts to foster Washington's biotech and life sciences sector," said Joseph Damond, senior vice president of international affairs at BIO. "During his time in the US House of Representatives, Governor Inslee was chosen as BIO's Legislator of the Year for his efforts to create an approval pathway for biosimilars. His perspective will be invaluable as China seeks to grow its biologics and biosimilars industry."
"China is a rapidly growing market for America's innovative biotechnology companies, including those in Washington State," said Inslee. "As this market continues to expand, it will be increasingly important to develop collaborative relationships with the Chinese government, companies, and academic institutions. The BIO Convention is China is a wonderful venue to build those relationships, and I am very glad to be able to attend this year."
The third annual BIO Convention in China will feature workshops including science-focused sessions such as vaccines, unmet medical needs and the research and development of orphan drugs to treat rare diseases in China. Business-focused sessions will explore China's private health care industry, early-stage VC funding in China, and partnering models between Chinese and Western companies.
Biotechnology Industry Organization represents biotechnology companies, academic institutions, state biotechnology centers and related organizations.
((Comments on this story may be sent to email@example.com))